biotech · Uveal Melanoma · Choroidal Melanoma · AURA
Aura Biosciences
Aura Biosciences patent portfolio — 17 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- Boston, USA
- Founded
- 2009
- Employees
- 128
- Programs
- 6
- Drugs
- 3
- Patents
- 17
Aura Biosciences patents
17 pharmaceutical patents indexed for Aura Biosciences. 1 expire within 24 months.
Aura Biosciences has 17 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 1 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
US 11786503
Pharmaceutical compositions and methods for countering chemotherapy induced cardiotoxicity
granted -
US 11166936
Pharmaceutical compositions and methods for countering chemotherapy induced cardiotoxicity
granted -
US 10874633
Pharmaceutical compositions and methods for countering chemotherapy induced cardiotoxicity
granted -
US 10806716
Pharmaceutical compositions and methods for countering chemotherapy induced cardiotoxicity
granted -
US 10688172
HPV particles and uses thereof
granted -
US 10596275
Virion-derived nanospheres for selective delivery of therapeutic and diagnostic agents to cancer cells
granted -
US 10300150
Virion-derived nanospheres for selective delivery of therapeutic and diagnostic agents to cancer cells
granted -
US 10179168
HPV particles and uses thereof
granted -
US 10076495
Structures for transdermal drug delivery
granted -
US 9855347
Virion-derived nanospheres for selective delivery of therapeutic and diagnostic agents to cancer cells
granted -
US 9724404
HPV particles and uses thereof
granted -
US 9700639
Virion-derived nanospheres for selective delivery of therapeutic and diagnostic agents to cancer cells
granted -
US 8852936
Autologous lymph node transfer in combination with VEGF-C or VEGF-D growth factor therapy to treat lymphedema and to improve reconstructive surgery
granted -
US 8758311
Transdermal patch with extensor means
granted -
US 8153609
Purine nucleotide derivatives
granted -
US 7790738
Methods of treating and preventing AIDS using of COX-2 inhibitors
granted -
US 7192932
Use of immunomodulating agents
granted
Frequently asked questions
How many patents does Aura Biosciences have?
17 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Aura Biosciences patents expire?
1 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.